← Other psychedelics

DOM

2,5-Dimethoxy-4-methylamphetamine

A psychedelic whose unusually long duration is central to its story.

C₁₂H₁₉NO₂View molecular structure

DOM is a synthetic psychedelic in the substituted amphetamine family, often grouped with the DOx compounds. It was also known historically as STP.

Its chemical family name can be confusing: DOM is discussed here for its psychedelic effects, not as another name for ordinary amphetamine.

DOM at a glance

Family
Substituted amphetamines · DOx
Type
Serotonergic psychedelic
Primary target
5-HT2A
Onset (oral)
Slow; can take several hours
Duration (oral)
Reported 14–20 hours
Origin
Synthetic

What is DOM?

DOM acts at serotonin receptors, including 5-HT2A, producing psychedelic effects. Its structure includes the amphetamine backbone, but chemical family alone does not determine a drug’s full action.

Its slow development and extended duration distinguish it from many better-known psychedelics.

The DOM experience

Sensory effects

Early accounts describe pronounced visual patterns and sustained changes in perception. The effects can develop slowly before becoming much more prominent.

Changes to sound are less systematically documented than the broader psychedelic effects. A consistent auditory profile has not been established.

Body sensations

A stimulating physical quality is commonly described. Over a long experience, tension, restlessness and fatigue may become particularly noticeable.

Headspace

Changes in thought can be absorbing, emotionally significant or confusing. Fascination and fear may coexist, and a slow beginning does not predict the eventual intensity.

Self, time and space

The experience can alter the sense of time while lasting many hours by the clock. Changes in self-awareness may also occur, but descriptions vary and controlled human evidence is limited.

History and culture

Alexander Shulgin developed DOM during his exploration of psychedelic phenethylamines. It entered the 1960s counterculture under the name STP.

Historical accounts of unexpectedly difficult experiences highlight confusion about strength and delayed onset. Those events shaped its reputation as much as descriptions of the psychedelic effects themselves.

Research and uses

DOM has been used in laboratory research on serotonergic psychedelic activity. Such work helps connect chemical structure, receptors and behaviour.

That research role should not be confused with an established therapeutic use. Contemporary controlled evidence about human benefits and long-term outcomes is limited.

Risks and considerations

Its slow onset can lead people to underestimate how much the effects are still developing. Its long duration adds risks related to exhaustion, distress and prolonged impairment.

Cardiovascular stimulation and severe psychological reactions are possible. Applying assumptions from shorter-acting compounds is particularly unreliable.

FAQ

Is DOM an ordinary stimulant?

No. Despite its substituted amphetamine structure, it has prominent psychedelic effects.

What does STP refer to?

It is a historical name associated with DOM’s circulation in the 1960s.

Is the duration fixed?

No. The reported range is approximate, with substantial individual and circumstance-dependent variation.

Sources
  1. Shulgin and Shulgin: PiHKAL, DOM
  2. NIH: Psychedelic and dissociative drugs
  3. PubChem: DOM molecular identity